You are here

Stability of citrate-capped silver nanoparticles in exposure media and their effects on the development of embryonic zebrafish (Danio rerio).

TitleStability of citrate-capped silver nanoparticles in exposure media and their effects on the development of embryonic zebrafish (Danio rerio).
Publication TypeJournal Article
Year of Publication2013
AuthorsPark K, Tuttle G, Sinche F, Harper S
JournalArch Pharm Res
Volume36
Issue1
Pagination125-33
Date Published2013 Jan
ISSN0253-6269
KeywordsAnimals, Citric Acid, Culture Media, Dose-Response Relationship, Drug, Drug Stability, Embryo, Nonmammalian, Embryonic Development, Environmental Exposure, Metal Nanoparticles, Particle Size, Silver, Water Pollutants, Chemical, Zebrafish
Abstract

The stability of citrate-capped silver nanoparticles (AgNPs) and the embryonic developmental toxicity were evaluated in the fish test water. Serious aggregation of AgNPs was observed in undiluted fish water (DM-100) in which high concentration of ionic salts exist. However, AgNPs were found to be stable for 7 days in DM-10, prepared by diluting the original fish water (DM-100) with deionized water to 10 %. The normal physiology of zebrafish embryos were evaluated in DM-10 to see if DM-10 can be used as a control vehicle for the embryonic fish toxicity test. As results, DM-10 without AgNPs did not induce any significant adverse effects on embryonic development of zebrafish determined by mortality, hatching, malformations and heart rate. When embryonic toxicity of AgNPs was tested in both DM-10 and in DM-100, AgNPs showed higher toxicity in DM-10 than in DM-100. This means that the big-sized aggregates of AgNPs were low toxic compared to the nano-sized AgNPs. AgNPs induced delayed hatching, decreased heart rate, pericardial edema, and embryo death. Accumulation of AgNPs in the embryo bodies was also observed. Based on this study, citrate-capped AgNPs are not aggregated in DM-10 and it can be used as a control vehicle in the toxicity test of fish embryonic development.

DOI10.1007/s12272-013-0005-x
Alternate JournalArch. Pharm. Res.
PubMed ID23325492
Grant ListES016896-01 / ES / NIEHS NIH HHS / United States
ES017552-01A2 / ES / NIEHS NIH HHS / United States
P30 ES03850 / ES / NIEHS NIH HHS / United States

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer